Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998

Israel Medical Association Journal

Volumn 4, Issue 9, 2002, Pages 671-676

  Merom, Dafna ^a   Ifrah, Anneke ^a   Cohen Manheim, Irit ^a   Chinich, Ayelet ^a   Green, Manfred S ^a  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

Healthcare services; Hormone replacement therapy; Israel; Menopause; Survey

Indexed keywords

ECONOMIC AND SOCIAL EFFECTS; GYNECOLOGY; HEALTH; HORMONES; SURVEYING;

HORMONE REPLACEMENT THERAPY (HRT);

MEDICAL APPLICATIONS;

HORMONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; AWARENESS; BODY MASS; CONFIDENCE INTERVAL; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH SURVEY; HIGH SCHOOL; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYSTERECTOMY; INTERVIEW; ISRAEL; JEW; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OVARIECTOMY; PHYSICIAN; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PREVALENCE; PREVENTIVE HEALTH SERVICE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK; SLEEP DISORDER; SOCIOECONOMICS; SWEATING; SYMPTOM; TELEPHONE; URINE INCONTINENCE; VAGINA DISEASE;

AGED; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH SURVEYS; HUMANS; ISRAEL; JEWS; LIFE STYLE; MIDDLE AGED; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREVALENCE; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 0036731643     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study
2. Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group
3. Estrogen replacement therapy and coronary heart disease: A qualitative assessment of the epidemiologic evidence
4. Postmenopausal hormone therapy and mortality
5. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
6. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
7. Hormones and breast cancer: Evidence and implications for consideration of risks and benefits of hormone replacement therapy
8. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
9. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism
10. Open debate on hormone-replacement therapy
11. Use of postmenopausal hormone-replacement therapy: Estimates from a nationally representative cohort study
12. Prevalence and characteristics associated with use of hormone-replacement therapy in Britain
13. Changes in the use of hormone replacement therapy in South Australia
14. HRT management: The American experience
15. Prior to use of estrogen replacement therapy, are users healthier than nonusers?
16. Women's attitudes towards menopause and hormone-replacement therapy
17. Patterns and correlates of hormone-replacement therapy use among middle-aged Australian women
18. Management of hormone replacement therapy: The Swedish experience
19. The perception of menopause in five ethnic groups in Israel
20. Hormone replacement therapy among Danish women aged 45-65 years: Prevalence, determinants and compliance
21. Hormone replacement therapy: Characteristics of users and non-users in a British general practice cohort identified through computerised prescribing records
22. Use of postmenopausal hormone-replacement therapy by African American women. The importance of physician discussion
23. The physician's role in women's decision making about hormone-replacement therapy
24. Prevalence of and factors associated with hormone replacement therapy counseling: Results from the 1994 National Health Interview Survey